Paul Weisman

Among the areas of investigation in contemporary breast pathology research, Dr. Weisman is particularly interested in triple negative breast carcinoma (TNBC). TNBCs, which represent 15-20% of all breast carcinomas, may have the most unmet patient needs among all of the breast carcinoma subtypes, simply because they may be either extremely deadly or highly curable and we lack many markers that can help us predict which tumors will fall into either category. Dr. Weisman is also interested in the morphology and molecular genetic alterations of hormone positive breast carcinomas at the time of acquired resistance to endocrine therapy.